Emerging medical treatments for aortic stenosis: statins, angiotensin converting enzyme inhibitors, or both?

Area of Science:

• Cardiology
• Valvular Heart Disease
• Medical Pathogenesis

Background:

• Aortic stenosis is the most prevalent adult heart valve disease globally, with increasing incidence.
• Current treatments do not modify the underlying disease progression of aortic stenosis.
• Pathogenesis of calcific aortic stenosis shares similarities with atherosclerosis.

Purpose of the Study:

• To describe the natural history and progression of calcific aortic stenosis.
• To review emerging medical treatments for aortic stenosis.
• To highlight potential disease-modifying therapies.

Main Methods:

• Literature review of calcific aortic stenosis.
• Analysis of emerging treatment strategies.
• Synthesis of current understanding of disease progression.

Main Results:

• Calcific aortic stenosis progression is not currently halted by established treatments.
• Statins and angiotensin-converting enzyme inhibitors show potential therapeutic benefits.
• Definitive evidence from large-scale clinical trials for new treatments is pending.

Conclusions:

• Further research and clinical trials are essential to validate new aortic stenosis treatments.
• Understanding the atherosclerotic-like nature of aortic stenosis may guide future therapies.
• Medical interventions targeting disease modification are a critical unmet need.